Share Price and Basic Stock Data
Last Updated: January 29, 2026, 7:17 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alfavision Overseas (India) Ltd, operating in a sector not explicitly identified, reported a significant decline in sales, with revenue for the fiscal year ending March 2023 standing at ₹58.58 Cr, down from ₹181.57 Cr in the previous year. This represents a staggering drop of approximately 67.7% year-on-year. Quarterly sales figures further illustrate this downward trend, with the last quarter of FY 2023 showing negative sales of ₹-1.74 Cr, following a series of fluctuating revenues throughout the previous quarters. Notably, sales peaked in FY 2021 at ₹179.10 Cr but have since shown a consistent decline, reflecting challenges in market demand or operational inefficiencies. The company’s ability to generate revenue from operations per share also diminished sharply, closing at ₹9.46 in FY 2023 compared to ₹575.94 in FY 2022. Overall, the revenue trajectory showcases a troubling pattern that warrants attention from stakeholders and potential investors.
Profitability and Efficiency Metrics
Alfavision’s profitability metrics reveal a challenging landscape. The company recorded a net profit of ₹-2.16 Cr in FY 2023, a stark contrast to a profit of ₹2.01 Cr in FY 2022. This downturn reflects a net profit margin of -3.69%, a significant decline from the positive margins of 1.10% the previous year. Operating profit also faced a decline, reported at ₹2.66 Cr for FY 2023, down from ₹4.93 Cr in FY 2022. The operating profit margin improved slightly to 4.54% from 2.72%, indicating that while operational efficiency may have marginally improved, the overall profitability remained under pressure. The interest coverage ratio fell to 0.55x, suggesting that the company’s earnings are insufficient to cover its interest obligations, a concerning indicator of financial health. Overall, these figures highlight a critical need for strategic operational adjustments to enhance profitability and efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Alfavision Overseas reveals a precarious financial position, characterized by a market capitalization of ₹15.7 Cr against total borrowings of ₹156.46 Cr. This results in a total debt-to-equity ratio of 3.62, indicating a highly leveraged position that may pose risks for future financial stability. Reserves stood at ₹37.08 Cr, which is a substantial decrease from ₹39.41 Cr in FY 2022, reflecting a shrinking cushion for potential operational challenges. The company’s return on equity (ROE) stood at 5.22%, while the return on capital employed (ROCE) was only 1.37%, both of which are notably low compared to typical sector standards. The interest coverage ratio of 0.55x further highlights the difficulty in meeting interest expenses, suggesting a need for immediate financial restructuring. These financial ratios underscore the urgent requirement for Alfavision to improve its asset utilization and capital management strategies.
Shareholding Pattern and Investor Confidence
The shareholding structure of Alfavision Overseas shows that promoters hold 24.80% of the equity, while the public holds a significant 75.19%. This distribution suggests a relatively high level of public ownership, which can be indicative of a broad investor base. However, the number of shareholders has been declining, from 3,294 in December 2022 to 3,228 by March 2025, which may signal waning investor confidence. The lack of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) further indicates a potential risk, as institutional backing often lends credibility and stability to a company. The dividend payout ratio for FY 2023 was reported at -7.57%, reflecting a lack of returns to shareholders amidst declining profitability, which may further dampen investor sentiment. Overall, the shareholding pattern presents a mixed picture, with high public ownership but declining shareholder numbers that could affect future capital raising efforts.
Outlook, Risks, and Final Insight
Looking ahead, Alfavision Overseas faces several risks that could impact its operational viability. The significant drop in revenue and net profit highlights the urgent need for the company to reassess its business strategy and operational efficiency. Risks include high leverage, as indicated by the debt-to-equity ratio of 3.62, which could strain cash flows if market conditions do not improve. Additionally, the declining number of shareholders suggests a potential loss of confidence among investors, which could hinder future fundraising efforts. On the other hand, there are opportunities for recovery if the company can streamline operations and improve revenue generation strategies. If Alfavision manages to stabilize its financials and regain investor trust, it could reverse its current trajectory. However, without decisive action, the ongoing financial challenges may continue to pose significant risks to its future sustainability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 102 Cr. | 26.6 | 776/20.5 | 0.99 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 3,021 Cr. | 187 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 35.6 Cr. | 2.79 | 7.55/2.70 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 6,661.42 Cr | 209.47 | 292.13 | 219.28 | 0.27% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 105.36 | 25.84 | 48.62 | 48.21 | 56.43 | 1.06 | 53.72 | 44.42 | 53.72 | 44.42 | 14.84 | 44.42 | -1.74 |
| Expenses | 102.93 | 25.85 | 48.48 | 46.73 | 54.52 | 0.66 | 52.67 | 42.89 | 52.67 | 42.89 | 12.47 | 42.89 | 0.12 |
| Operating Profit | 2.43 | -0.01 | 0.14 | 1.48 | 1.91 | 0.40 | 1.05 | 1.53 | 1.05 | 1.53 | 2.37 | 1.53 | -1.86 |
| OPM % | 2.31% | -0.04% | 0.29% | 3.07% | 3.38% | 37.74% | 1.95% | 3.44% | 1.95% | 3.44% | 15.97% | 3.44% | |
| Other Income | -0.08 | 0.73 | 0.23 | 0.23 | 0.23 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 2.16 | 0.68 | 0.31 | 1.32 | 0.84 | 0.60 | 0.61 | 1.07 | 0.61 | 1.07 | 1.16 | 1.07 | 1.32 |
| Depreciation | -0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.00 | 0.03 | 0.00 | 0.03 | 0.00 | 0.03 | 0.02 |
| Profit before tax | 0.21 | 0.02 | 0.03 | 0.36 | 1.28 | 0.02 | 0.44 | 0.43 | 0.44 | 0.43 | 1.21 | 0.43 | -3.19 |
| Tax % | 42.86% | 0.00% | 33.33% | 0.00% | 20.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.31% |
| Net Profit | 0.13 | 0.02 | 0.02 | 0.37 | 1.01 | 0.03 | 0.44 | 0.44 | 0.44 | 0.44 | 1.21 | 0.44 | -3.20 |
| EPS in Rs | 0.04 | 0.01 | 0.01 | 0.12 | 0.32 | 0.01 | 0.14 | 0.14 | 0.14 | 0.14 | 0.38 | 0.14 | -1.02 |
Last Updated: Unknown
Below is a detailed analysis of the quarterly data for Alfavision Overseas (India) Ltd based on the most recent figures (Mar 2023) and their trends compared to the previous period:
- For Sales, as of Mar 2023, the value is -1.74 Cr.. The value appears to be declining and may need further review. It has decreased from 44.42 Cr. (Dec 2022) to -1.74 Cr., marking a decrease of 46.16 Cr..
- For Expenses, as of Mar 2023, the value is 0.12 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 42.89 Cr. (Dec 2022) to 0.12 Cr., marking a decrease of 42.77 Cr..
- For Operating Profit, as of Mar 2023, the value is -1.86 Cr.. The value appears to be declining and may need further review. It has decreased from 1.53 Cr. (Dec 2022) to -1.86 Cr., marking a decrease of 3.39 Cr..
- For OPM %, as of Mar 2023, the value is 0.00%. The value appears to be declining and may need further review. It has decreased from 3.44% (Dec 2022) to 0.00%, marking a decrease of 3.44%.
- For Other Income, as of Mar 2023, the value is 0.01 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2022) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Mar 2023, the value is 1.32 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.07 Cr. (Dec 2022) to 1.32 Cr., marking an increase of 0.25 Cr..
- For Depreciation, as of Mar 2023, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Dec 2022) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Mar 2023, the value is -3.19 Cr.. The value appears to be declining and may need further review. It has decreased from 0.43 Cr. (Dec 2022) to -3.19 Cr., marking a decrease of 3.62 Cr..
- For Tax %, as of Mar 2023, the value is 0.31%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Dec 2022) to 0.31%, marking an increase of 0.31%.
- For Net Profit, as of Mar 2023, the value is -3.20 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Dec 2022) to -3.20 Cr., marking a decrease of 3.64 Cr..
- For EPS in Rs, as of Mar 2023, the value is -1.02. The value appears to be declining and may need further review. It has decreased from 0.14 (Dec 2022) to -1.02, marking a decrease of 1.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Sales | 98.59 | 116.45 | 156.98 | 179.10 | 181.57 | 58.58 |
| Expenses | 96.66 | 114.06 | 153.65 | 175.04 | 176.64 | 55.92 |
| Operating Profit | 1.93 | 2.39 | 3.33 | 4.06 | 4.93 | 2.66 |
| OPM % | 1.96% | 2.05% | 2.12% | 2.27% | 2.72% | 4.54% |
| Other Income | 0.19 | 0.10 | 0.00 | 0.92 | 1.23 | 0.01 |
| Interest | 1.76 | 2.16 | 2.98 | 3.19 | 3.98 | 4.77 |
| Depreciation | 0.17 | 0.18 | 0.09 | 0.10 | 0.10 | 0.05 |
| Profit before tax | 0.19 | 0.15 | 0.26 | 1.69 | 2.08 | -2.15 |
| Tax % | -10.53% | -20.00% | 34.62% | 12.43% | 3.37% | 0.47% |
| Net Profit | 0.22 | 0.18 | 0.17 | 1.49 | 2.01 | -2.16 |
| EPS in Rs | 0.07 | 0.06 | 0.05 | 0.47 | 0.64 | -0.69 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 4.23% | 7.84% | 0.00% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -18.18% | -5.56% | 776.47% | 34.90% | -207.46% |
| Change in YoY Net Profit Growth (%) | 0.00% | 12.63% | 782.03% | -741.57% | -242.36% |
Alfavision Overseas (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2018-2019 to 2022-2023.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -10% |
| 3 Years: | -28% |
| TTM: | -68% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -207% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 23% |
| 3 Years: | -42% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | -5% |
Last Updated: September 5, 2025, 2:11 pm
Balance Sheet
Last Updated: July 25, 2025, 1:56 pm
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Equity Capital | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 |
| Reserves | 5.01 | 5.13 | 5.29 | 7.32 | 39.41 | 37.08 |
| Borrowings | 24.59 | 29.30 | 49.15 | 54.67 | 143.08 | 156.46 |
| Other Liabilities | 10.82 | 23.97 | 43.57 | 50.30 | 131.23 | 8.15 |
| Total Liabilities | 43.57 | 61.55 | 101.16 | 115.44 | 316.87 | 204.84 |
| Fixed Assets | 0.50 | 0.48 | 0.46 | 0.53 | 30.44 | 30.41 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.59 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 42.48 | 60.59 | 100.70 | 114.91 | 286.43 | 174.43 |
| Total Assets | 43.57 | 61.55 | 101.16 | 115.44 | 316.87 | 204.84 |
Below is a detailed analysis of the balance sheet data for Alfavision Overseas (India) Ltd based on the most recent figures (Mar 2023) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2023, the value is 3.15 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded 3.15 Cr..
- For Reserves, as of Mar 2023, the value is 37.08 Cr.. The value appears to be declining and may need further review. It has decreased from 39.41 Cr. (Mar 2022) to 37.08 Cr., marking a decrease of 2.33 Cr..
- For Borrowings, as of Mar 2023, the value is 156.46 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 143.08 Cr. (Mar 2022) to 156.46 Cr., marking an increase of 13.38 Cr..
- For Other Liabilities, as of Mar 2023, the value is 8.15 Cr.. The value appears to be improving (decreasing). It has decreased from 131.23 Cr. (Mar 2022) to 8.15 Cr., marking a decrease of 123.08 Cr..
- For Total Liabilities, as of Mar 2023, the value is 204.84 Cr.. The value appears to be improving (decreasing). It has decreased from 316.87 Cr. (Mar 2022) to 204.84 Cr., marking a decrease of 112.03 Cr..
- For Fixed Assets, as of Mar 2023, the value is 30.41 Cr.. The value appears to be declining and may need further review. It has decreased from 30.44 Cr. (Mar 2022) to 30.41 Cr., marking a decrease of 0.03 Cr..
- For CWIP, as of Mar 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded 0.00 Cr..
- For Investments, as of Mar 2023, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2023, the value is 174.43 Cr.. The value appears to be declining and may need further review. It has decreased from 286.43 Cr. (Mar 2022) to 174.43 Cr., marking a decrease of 112.00 Cr..
- For Total Assets, as of Mar 2023, the value is 204.84 Cr.. The value appears to be declining and may need further review. It has decreased from 316.87 Cr. (Mar 2022) to 204.84 Cr., marking a decrease of 112.03 Cr..
However, the Borrowings (156.46 Cr.) are higher than the Reserves (37.08 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -22.66 | -26.91 | -45.82 | -50.61 | -138.15 | -153.80 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
No data available for the Financial Efficiency data table.
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -6.87 | 6.38 | 0.45 | 0.53 | 0.57 |
| Diluted EPS (Rs.) | -6.87 | 6.38 | 0.45 | 0.53 | 0.57 |
| Cash EPS (Rs.) | -0.34 | 6.70 | 4.87 | 0.81 | 1.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 6.99 | 144.65 | 42.70 | 38.15 | 31.71 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 6.99 | 144.65 | 42.70 | 38.15 | 31.71 |
| Revenue From Operations / Share (Rs.) | 9.46 | 575.94 | 568.10 | 497.94 | 369.39 |
| PBDIT / Share (Rs.) | 0.42 | 19.54 | 15.65 | 10.57 | 7.91 |
| PBIT / Share (Rs.) | 0.41 | 19.23 | 15.34 | 10.29 | 7.33 |
| PBT / Share (Rs.) | -0.34 | 6.59 | 5.37 | 0.82 | 0.47 |
| Net Profit / Share (Rs.) | -0.34 | 6.38 | 4.55 | 0.53 | 0.50 |
| NP After MI And SOA / Share (Rs.) | -0.34 | 6.38 | 4.55 | 0.53 | 0.50 |
| PBDIT Margin (%) | 4.50 | 3.39 | 2.75 | 2.12 | 2.14 |
| PBIT Margin (%) | 4.42 | 3.33 | 2.69 | 2.06 | 1.98 |
| PBT Margin (%) | -3.67 | 1.14 | 0.94 | 0.16 | 0.12 |
| Net Profit Margin (%) | -3.69 | 1.10 | 0.80 | 0.10 | 0.13 |
| NP After MI And SOA Margin (%) | -3.69 | 1.10 | 0.80 | 0.10 | 0.13 |
| Return on Networth / Equity (%) | -5.00 | 4.41 | 14.58 | 1.99 | 1.92 |
| Return on Capital Employeed (%) | 1.29 | 3.46 | 13.10 | 10.12 | 15.33 |
| Return On Assets (%) | -1.05 | 0.63 | 1.23 | 0.16 | 0.25 |
| Long Term Debt / Equity (X) | 3.62 | 2.83 | 2.38 | 2.36 | 0.61 |
| Total Debt / Equity (X) | 3.62 | 3.14 | 5.56 | 5.81 | 3.54 |
| Asset Turnover Ratio (%) | 0.22 | 0.49 | 1.04 | 1.13 | 1.41 |
| Current Ratio (X) | 1.06 | 1.28 | 1.27 | 1.24 | 1.30 |
| Quick Ratio (X) | 1.06 | 1.28 | 1.26 | 1.24 | 1.30 |
| Dividend Payout Ratio (NP) (%) | -7.57 | 3.13 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | -7.74 | 2.98 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 107.57 | 96.87 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 107.74 | 97.02 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.55 | 1.55 | 1.57 | 1.12 | 1.15 |
| Interest Coverage Ratio (Post Tax) (X) | 0.54 | 1.51 | 1.46 | 1.06 | 1.07 |
| Enterprise Value (Cr.) | 222.71 | 183.17 | 70.22 | 60.10 | 41.62 |
| EV / Net Operating Revenue (X) | 3.80 | 1.01 | 0.39 | 0.38 | 0.35 |
| EV / EBITDA (X) | 84.39 | 29.73 | 14.23 | 18.03 | 16.68 |
| MarketCap / Net Operating Revenue (X) | 1.13 | 0.22 | 0.06 | 0.05 | 0.09 |
| Retention Ratios (%) | 107.57 | 96.86 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.53 | 0.89 | 1.23 | 0.94 | 1.32 |
| Price / Net Operating Revenue (X) | 1.13 | 0.22 | 0.06 | 0.05 | 0.09 |
| EarningsYield | -0.03 | 0.04 | 0.11 | 0.02 | 0.01 |
After reviewing the key financial ratios for Alfavision Overseas (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 22) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 23, the value is -6.87. This value is below the healthy minimum of 5. It has decreased from 6.38 (Mar 22) to -6.87, marking a decrease of 13.25.
- For Diluted EPS (Rs.), as of Mar 23, the value is -6.87. This value is below the healthy minimum of 5. It has decreased from 6.38 (Mar 22) to -6.87, marking a decrease of 13.25.
- For Cash EPS (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 3. It has decreased from 6.70 (Mar 22) to -0.34, marking a decrease of 7.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 6.99. It has decreased from 144.65 (Mar 22) to 6.99, marking a decrease of 137.66.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 6.99. It has decreased from 144.65 (Mar 22) to 6.99, marking a decrease of 137.66.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 9.46. It has decreased from 575.94 (Mar 22) to 9.46, marking a decrease of 566.48.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 0.42. This value is below the healthy minimum of 2. It has decreased from 19.54 (Mar 22) to 0.42, marking a decrease of 19.12.
- For PBIT / Share (Rs.), as of Mar 23, the value is 0.41. This value is within the healthy range. It has decreased from 19.23 (Mar 22) to 0.41, marking a decrease of 18.82.
- For PBT / Share (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 0. It has decreased from 6.59 (Mar 22) to -0.34, marking a decrease of 6.93.
- For Net Profit / Share (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 2. It has decreased from 6.38 (Mar 22) to -0.34, marking a decrease of 6.72.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is -0.34. This value is below the healthy minimum of 2. It has decreased from 6.38 (Mar 22) to -0.34, marking a decrease of 6.72.
- For PBDIT Margin (%), as of Mar 23, the value is 4.50. This value is below the healthy minimum of 10. It has increased from 3.39 (Mar 22) to 4.50, marking an increase of 1.11.
- For PBIT Margin (%), as of Mar 23, the value is 4.42. This value is below the healthy minimum of 10. It has increased from 3.33 (Mar 22) to 4.42, marking an increase of 1.09.
- For PBT Margin (%), as of Mar 23, the value is -3.67. This value is below the healthy minimum of 10. It has decreased from 1.14 (Mar 22) to -3.67, marking a decrease of 4.81.
- For Net Profit Margin (%), as of Mar 23, the value is -3.69. This value is below the healthy minimum of 5. It has decreased from 1.10 (Mar 22) to -3.69, marking a decrease of 4.79.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is -3.69. This value is below the healthy minimum of 8. It has decreased from 1.10 (Mar 22) to -3.69, marking a decrease of 4.79.
- For Return on Networth / Equity (%), as of Mar 23, the value is -5.00. This value is below the healthy minimum of 15. It has decreased from 4.41 (Mar 22) to -5.00, marking a decrease of 9.41.
- For Return on Capital Employeed (%), as of Mar 23, the value is 1.29. This value is below the healthy minimum of 10. It has decreased from 3.46 (Mar 22) to 1.29, marking a decrease of 2.17.
- For Return On Assets (%), as of Mar 23, the value is -1.05. This value is below the healthy minimum of 5. It has decreased from 0.63 (Mar 22) to -1.05, marking a decrease of 1.68.
- For Long Term Debt / Equity (X), as of Mar 23, the value is 3.62. This value exceeds the healthy maximum of 1. It has increased from 2.83 (Mar 22) to 3.62, marking an increase of 0.79.
- For Total Debt / Equity (X), as of Mar 23, the value is 3.62. This value exceeds the healthy maximum of 1. It has increased from 3.14 (Mar 22) to 3.62, marking an increase of 0.48.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.22. It has decreased from 0.49 (Mar 22) to 0.22, marking a decrease of 0.27.
- For Current Ratio (X), as of Mar 23, the value is 1.06. This value is below the healthy minimum of 1.5. It has decreased from 1.28 (Mar 22) to 1.06, marking a decrease of 0.22.
- For Quick Ratio (X), as of Mar 23, the value is 1.06. This value is within the healthy range. It has decreased from 1.28 (Mar 22) to 1.06, marking a decrease of 0.22.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is -7.57. This value is below the healthy minimum of 20. It has decreased from 3.13 (Mar 22) to -7.57, marking a decrease of 10.70.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is -7.74. This value is below the healthy minimum of 20. It has decreased from 2.98 (Mar 22) to -7.74, marking a decrease of 10.72.
- For Earning Retention Ratio (%), as of Mar 23, the value is 107.57. This value exceeds the healthy maximum of 70. It has increased from 96.87 (Mar 22) to 107.57, marking an increase of 10.70.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 107.74. This value exceeds the healthy maximum of 70. It has increased from 97.02 (Mar 22) to 107.74, marking an increase of 10.72.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 0.55. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 22) to 0.55, marking a decrease of 1.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 0.54. This value is below the healthy minimum of 3. It has decreased from 1.51 (Mar 22) to 0.54, marking a decrease of 0.97.
- For Enterprise Value (Cr.), as of Mar 23, the value is 222.71. It has increased from 183.17 (Mar 22) to 222.71, marking an increase of 39.54.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 3.80. This value exceeds the healthy maximum of 3. It has increased from 1.01 (Mar 22) to 3.80, marking an increase of 2.79.
- For EV / EBITDA (X), as of Mar 23, the value is 84.39. This value exceeds the healthy maximum of 15. It has increased from 29.73 (Mar 22) to 84.39, marking an increase of 54.66.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 1.13. This value is within the healthy range. It has increased from 0.22 (Mar 22) to 1.13, marking an increase of 0.91.
- For Retention Ratios (%), as of Mar 23, the value is 107.57. This value exceeds the healthy maximum of 70. It has increased from 96.86 (Mar 22) to 107.57, marking an increase of 10.71.
- For Price / BV (X), as of Mar 23, the value is 1.53. This value is within the healthy range. It has increased from 0.89 (Mar 22) to 1.53, marking an increase of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 1.13. This value is within the healthy range. It has increased from 0.22 (Mar 22) to 1.13, marking an increase of 0.91.
- For EarningsYield, as of Mar 23, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 22) to -0.03, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alfavision Overseas (India) Ltd:
- Net Profit Margin: -3.69%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.29% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.54
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.06
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 292.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.62
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -3.69%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | 135, Old Gauri Nagar Indore Madhya Pradesh 452010 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vishnu Prasad Goyal | Chairman & Managing Director |
| Mr. Ravi Goyal | Non Executive Director & CFO |
| Mrs. Niharika Roongta | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Alfavision Overseas (India) Ltd?
Alfavision Overseas (India) Ltd's intrinsic value (as of 29 January 2026) is ₹7.31 which is 49.18% higher the current market price of ₹4.90, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹15.4 Cr. market cap, FY2025-2026 high/low of ₹15.9/4.54, reserves of ₹37.08 Cr, and liabilities of ₹204.84 Cr.
What is the Market Cap of Alfavision Overseas (India) Ltd?
The Market Cap of Alfavision Overseas (India) Ltd is 15.4 Cr..
What is the current Stock Price of Alfavision Overseas (India) Ltd as on 29 January 2026?
The current stock price of Alfavision Overseas (India) Ltd as on 29 January 2026 is ₹4.90.
What is the High / Low of Alfavision Overseas (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alfavision Overseas (India) Ltd stocks is ₹15.9/4.54.
What is the Stock P/E of Alfavision Overseas (India) Ltd?
The Stock P/E of Alfavision Overseas (India) Ltd is .
What is the Book Value of Alfavision Overseas (India) Ltd?
The Book Value of Alfavision Overseas (India) Ltd is 12.8.
What is the Dividend Yield of Alfavision Overseas (India) Ltd?
The Dividend Yield of Alfavision Overseas (India) Ltd is 0.00 %.
What is the ROCE of Alfavision Overseas (India) Ltd?
The ROCE of Alfavision Overseas (India) Ltd is 1.37 %.
What is the ROE of Alfavision Overseas (India) Ltd?
The ROE of Alfavision Overseas (India) Ltd is 5.22 %.
What is the Face Value of Alfavision Overseas (India) Ltd?
The Face Value of Alfavision Overseas (India) Ltd is 1.00.